Compounds > gefitinib
Page last updated: 2024-09-03

gefitinib and Mucormycosis

gefitinib has been researched along with Mucormycosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alkhazraji, S; Alqarihi, A; Alsaadi, AI; Bruno, VM; Edwards, VL; Filler, SG; Gebremariam, T; Graf, KT; Ibrahim, AS; Shetty, AC; Swidergall, M; Watkins, TN1

Other Studies

1 other study(ies) available for gefitinib and Mucormycosis

ArticleYear
Inhibition of EGFR Signaling Protects from Mucormycosis.
    mBio, 2018, 08-14, Volume: 9, Issue:4

    Topics: A549 Cells; Animals; Cetuximab; Disease Models, Animal; ErbB Receptors; Gefitinib; Gene Regulatory Networks; Host-Pathogen Interactions; Humans; Lung; Male; Mice; Mice, Inbred ICR; Mucormycosis; Phosphorylation; Protein Kinase Inhibitors; Rhizopus; Sequence Analysis, RNA; Signal Transduction

2018